These data demonstrated that reducing the dose of tPA in routine use (all comers) is not associated with a decrease in pleural bleeding incidence, perhaps suggesting that the dose effect for bleeding is different in intrapleural vs IV use.20 This evidence concerns the gene PLAT and Abnormal bleeding.